Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease - Concepedia

Concepedia

Publication | Closed Access

Characterization of CCX282-B, an Orally Bioavailable Antagonist of the CCR9 Chemokine Receptor, for Treatment of Inflammatory Bowel Disease

158

Citations

30

References

2010

Year

Matthew J. Walters, Yu Wang, Trageen Baumgart, Bin Zhao, Daniel J. Dairaghi, Pirow Bekker, Linda Ertl, Mark E.T. Penfold, Juan C. Jaén, Satish Keshav,

Journal of Pharmacology and Experimental Therapeutics

References

	Year	Citations

Page 1